Can the Intrinsic Power of Branching Morphogenesis Be Used for Engineering Epithelial Tissues and Organs?

Stem Cells Transl Med. 2013 Nov 4. [Epub ahead of print]

Concise Review: Can the Intrinsic Power of Branching Morphogenesis Be Used for Engineering Epithelial Tissues and Organs?

Nigam SK.

Source

Departments of Pediatrics, Medicine, Cellular and Molecular Medicine, and Bioengineering, University of California San Diego, La Jolla, California, USA.

Abstract

Branching Morphogenesis Is Critical to the Development of Organs Such as Kidney, Lung, Mammary Gland, Prostate, Pancreas, and Salivary Gland. Essentially, an Epithelial Bud Becomes an Iterative Tip-Stalk Generator (itsg) Able to Form a Tree of Branching Ducts And/Or Tubules. in Different Organs, Branching Morphogenesis Is Governed by Similar Sets of Genes. Epithelial Branching Has Been Recapitulated in Vitro (or Ex VIVO) Using Three-Dimensional Cell Culture and Partial Organ Culture Systems, and Several Such Systems Relevant to Kidney Tissue Engineering Are Discussed Here. by Adapting Systems like These It May be Possible to Harness the Power Inherent in the Itsg Program to Propagate and Engineer Epithelial Tissues and Organs. It Is Also Possible to Conceive of a Universal Itsg Capable of Propagation that May, by Recombination with Organ-Specific Mesenchymal Cells, be Used for Engineering Many Organ-like Tissues Similar to the Organ from which the Mesenchyme Cells Were Derived, or Toward which They Are Differentiated (from Stem Cells). the Three-Dimensional (3D) Branched Epithelial Structure Could Act as a Dynamic Branching Cellular Scaffold to Establish the Architecture for the Rest of the Tissue. Another Strategy-that of recombining propagated organ-specific ITSGs in 3D culture with undifferentiated mesenchymal stem cells-is also worth exploring. If feasible, such engineered tissues may be useful for the ex vivo study of drug toxicity, developmental biology, and physiology in the laboratory. Over the long term, they have potential clinical applications in the general fields of transplantation, regenerative medicine, and bioartificial medical devices to aid in the treatment of chronic kidney disease, diabetes, and other diseases.